• Search
  • Helpdesk
  • Sales contact

eCOA in ophthalmology

9 July 2020

There is an extended use of Patient Reported Outcome (PRO) measures in clinical trials used to assess health-related quality of life, symptoms, or perception of health status by the patients participating in clinical research. These measures are increasingly being collected via electronic devices and are, as such, referred to as ePROs.

In ophthalmology trials, the types of ePRO used can be general (SF-36, EQ-5D), vision specific (VFQ-25) or condition specific (glaucoma utility index, Retinopathy Treatment Satisfaction Questionnaire). A very wide range of validated questionnaires are available for use in research and selecting the right ePRO in an ophthalmology study is paramount to the success of a clinical trial.


Discover the five keys for successful ePRO selection in your ophthalmology clinical trial:

Follow us on LinkedIn to stay up-to-date on our latest videos:

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

Mobile in Clinical Trials

16 SEPT 2024 • Philadelphia, USA
https://mobileinclinicaltrials.com/

DPharm 2024

17-18 SEPT 2024 • Philadelphia, USA
https://dpharmconference.com/   

SCDM 2024

29 SEPT - 2 OCT 2024 • Boston, USA
https://scdmlive.org/annual-conference-2024/      

ISOQOL 2024

13-16 OCT 2024 • Cologne, Germany
https://www.isoqol.org/    

CNS SUMMIT 2024

10-13 NOV 2024 • Cologne, Germany
https://cnssummit.org/the-summit/  

DMB 2024

13 NOV 2024 • Paris, France
https://dmb-asso.org/

SCOPE 2025

FEB 3-6 2025 • Orlando, USA
Booth #931 https://www.scopesummit.com/